Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Fight the Formation of Expression Lines with PCA SKIN®'s New Targeted Neuropeptide Spot Treatment, ExLinea Pro Peptide Serum

This breakthrough innovation proved effective for 100% of patients in a clinical study


News provided by

PCA SKIN

Aug 17, 2021, 09:08 ET

Share this article

Share toX

Share this article

Share toX

SCOTTSDALE, Ariz., Aug. 17, 2021 /PRNewswire/ -- PCA SKIN®, a leader in professional peel treatments and transformative daily skincare products, introduces their newest, most advanced corrective, ExLinea® Pro Peptide Serum. This clinically proven formula features the brand's Peptide-Pro Complex providing immediate and long-term reduction of facial expression lines.

Continue Reading
Fight the Formation of Expression Lines with PCA SKIN®’s New Targeted Neuropeptide Spot Treatment, ExLinea Pro Peptide Serum
Fight the Formation of Expression Lines with PCA SKIN®’s New Targeted Neuropeptide Spot Treatment, ExLinea Pro Peptide Serum
Fight the Formation of Expression Lines with PCA SKIN®’s New Targeted Neuropeptide Spot Treatment, ExLinea Pro Peptide Serum
Fight the Formation of Expression Lines with PCA SKIN®’s New Targeted Neuropeptide Spot Treatment, ExLinea Pro Peptide Serum
Fight the Formation of Expression Lines with PCA SKIN®’s New Targeted Neuropeptide Spot Treatment, ExLinea Pro Peptide Serum
Fight the Formation of Expression Lines with PCA SKIN®’s New Targeted Neuropeptide Spot Treatment, ExLinea Pro Peptide Serum

With a groundbreaking ingredient blend and proven efficacious levels of neuropeptides, proteins, amino acids and marine extracts, the proprietary Peptide-Pro Complex works across both the epidermis and dermis to visibly reduce expression lines caused by repeated muscle movement.

"At PCA SKIN, it's our constant endeavor to develop the most clinically advanced correctives which will truly transform people's skin health. We are proud to introduce this new peptide packed serum to professionals and consumers as a superior option to combat expression lines," said PCA SKIN®️ CEO Joanna Zucker. "The clinical study we conducted has produced impressive results across a range of patients providing even more reasons to believe in this truly transformative product."

PCA SKIN Peptide-Pro Complex features the Ex-Factor of ingredients including:

  • Snap-8™ Peptide (Acetyl Octapeptide-3): A neuropeptide that helps reduce the depth of fine lines and wrinkles caused by facial muscle contractions.
  • Argireline® Amplified Peptide (Acetyl Hexapeptide-8): A multi-functional peptide that helps to minimize the appearance of expression lines and visible signs of aging.
  • Polysaccharide-Amino Acid Blend: An effective monolayer composed of proteins, algae, and amino acids that boosts the skin's moisture retention and the penetration of other functional ingredients. It enhances elasticity and helps smooth, hydrate, and lift skin.
  • Bacillus/Soybean Ferment Extract: A marine extract that provides a contouring and firming effect on loose skin, improving the overall appearance of sagging skin.

Clinically Proven Results:
The ExLinea Pro Peptide Serum was tested on 31 female participants between the ages of 35 and 55 years old with Fitzpatrick types ranging from I to III. The study evaluated the product's effects on the skin when applied twice daily over 12 weeks. The results?

  • Expression Line Reduction: 100% of patients showed a visible reduction in fine lines and wrinkles after 12 weeks
  • Lifting and Tightening: 100% of patients showed a visible lifting and tightening effect after 4 weeks
  • Skin Smoothing: 100% of patients showed an improvement in skin smoothness and texture after 4 weeks
  • PERCENTAGE OF IMPROVEMENT AFTER 12 WEEKS OF USE

Patient Satisfaction & Key Benefits:
Backed by robust clinical data, this breakthrough Peptide-Pro Complex makes expression lines an issue of the past with benefits and proven results including:

  • Immediate and long-term reduction of visible expression lines
  • Lifted, tightened and firmed skin
  • Strengthened skin by improving epidermal thickness
  • Reduced skin roughness for a smoother skin texture
  • Increased hydration and moisture retention

With consistent, continued use of the ExLinea Pro Peptide Serum, clinical results proved exemplary satisfaction levels with:

  • 97% of patients shared they felt skin was smoother after 4 weeks
  • 94% of patients said their skin was firmer after 4 weeks
  • 94% of patients felt their skin looked younger after 12 weeks

PCA SKIN® ExLinea Pro Peptide Serum ($135) is available at www.pcaskin.com. For more information on research and clinical study results visit www.pcaskin.com/exlineapro.

PCA SKIN®
Founded in 1990 as Physician's Choice of Arizona, Inc. by an aesthetician working with a handful of physicians, the company later evolved into Physicians Care Alliance, LLC, a global organization serving over 13,000 medical and aesthetic practices, with products sold in over 35 countries. PCA SKIN® has been and continues to be a trusted innovator in the development of highly effective professional treatments and daily care products with the vision to improve people's lives by providing results-oriented, transformative skin care solutions that are backed by science for the health of your unique skin. PCA SKIN treatments and products are available through licensed skin health professionals that have been trained and certified by PCA SKIN in their use. www.PCASkin.com | Facebook.com/pcaskin|@pcaskin

SOURCE PCA SKIN

Related Links

http://www.pcaskin.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

PCA SKIN® Introduces MGF Age Renewal Cream: A Breakthrough for Thinning Skin

PCA SKIN® Introduces MGF Age Renewal Cream: A Breakthrough for Thinning Skin

PCA SKIN®, the trusted leader in professional treatments and science-backed skincare, is redefining what an age-defying cream can do. The brand...

PCA SKIN® Partners with Celebrity Master Esthetician, Candice Miele to Introduce the Power of Professional Peels and At-Home Corrective Care to get A-list Skin

PCA SKIN® Partners with Celebrity Master Esthetician, Candice Miele to Introduce the Power of Professional Peels and At-Home Corrective Care to get A-list Skin

PCA SKIN, a trusted leader in professional treatments and science-backed skincare solutions is refining its approach to skin transformation as the...

More Releases From This Source

Explore

Cosmetics and Personal Care

Cosmetics and Personal Care

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

Supplementary Medicine

Supplementary Medicine

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.